MR biopsy versus MR guided ultrasound fusion biopsy in prostate cancer diagnosis

• Conditions: Prostate cancer; Prostate carcinoma; 10027656; 10036958

• Registration Number: NL-OMON38691
• Lead Sponsor: niversitair Medisch Centrum Sint Radboud

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 50

Inclusion Criteria

- At least one negatieve systematic ultrasound guided biopsy
- MR-visible tumor >10 mm diameter
- PI-RADS 4-5

Exclusion Criteria

- MR-visible tumor <10 mm diameter
- PI-RADS 1-3
- Patients with previous radiotherapy, hormonal therapy or local treatment of the prostate
- Contra-indication for MR imaging

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The main study parameter is the percent change in success rate of MRgUSBx to<br /><br>MRgMRBx. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Other parameters include changes in spatial accuracy, procedure times, and<br /><br>detection rates.</p><br>